Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 8/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | PSMB5 | P28074 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eriodictyol SCHEMBL19180 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL29709569 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL29382523 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL30468822 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL29603762 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL23686074 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Eriodictyol SCHEMBL29378971 | 1.00 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Naringenin SCHEMBL1048136 | 0.89 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Naringenin SCHEMBL20570 | 0.89 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 | |
| Naringenin SCHEMBL20571 | 0.89 | CYP19A1 (1.00) | CYP19A1CYP3A4CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210290514-A1 | An Antimicrobial Combination Composition Comprising Glycerol Derivatives and Bicyclic Compounds | SACHEM EUROPE B.V. (NL) | 2021-09-23 | — | — | US | claimed |
| CN-112955113-A | Antimicrobial binding compositions comprising glycerol derivatives and bicyclic compounds | 科莱恩国际有限公司 | 2021-06-11 | — | — | CN | claimed |
| EP-3817712-A1 | AN ANTIMICROBIAL COMBINATION COMPOSITION COMPRISING GLYCEROL DERIVATIVES AND BICYCLIC COMPOUNDS | Clariant International Ltd (CH) | 2021-05-12 | — | — | EP | claimed |
| WO-2020007571-A1 | AN ANTIMICROBIAL COMBINATION COMPOSITION COMPRISING GLYCEROL DERIVATIVES AND BICYCLIC COMPOUNDS | CLARIANT INTERNATIONAL LTD (CH) | 2020-01-09 | — | — | WO | claimed |
| EP-1258200-B1 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | SYMRISE GMBH & CO KG (DE) | 2005-02-16 | — | — | EP | claimed |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | SYMRISE AG (DE) | 2002-12-12 | — | — | US | claimed |
| EP-1258200-A2 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | HAARMANN & REIMER GMBH (DE) | 2002-11-20 | — | — | EP | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
| JP-62145016-A | — | — | None | — | — | JP | disclosed |
| EP-4746880-A2 | METHODS OF TREATING DILATED CARDIOMYOPATHY | Regencor, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3723723-B1 | EXTRACT OF THE AERIAL PARTS OF LAWSONIA INERMIS AND ITS PREPARATION METHOD | PIERRE FABRE DERMO COSMETIQUE (FR) | 2026-03-18 | — | — | EP | disclosed |
| EP-4699452-A2 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | Symrise AG (DE) | 2026-02-25 | — | — | EP | disclosed |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | INT FLAVORS & FRAGRANCES INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-3836799-B1 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | SYMRISE AG (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-5229113-A | Gene expression, soybeans | LUBRIZOL GENETICS, INC. (US) | 1993-07-20 | — | — | US | disclosed |
| US-5023180-A | Bradyrhizobium japonicum nodulation regulatory protein and gene | LUBRIZOL GENETICS, INC. (US) | 1991-06-11 | — | — | US | disclosed |
| JP-S62145016-A | ANTIBACTERIAL AGENT | MITSUBISHI CHEM IND LTD | 1987-06-29 | — | — | JP | disclosed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210290514-A1 | An Antimicrobial Combination Composition Comprising Glycerol Derivatives and Bicyclic Compounds | GK, MGLL, UGCG | CYP19A1 1248/4885CYP3A4 2337/4885CYP1A1 2314/4885 |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | TAS2R60, TAS2R50, TAS2R30 | CYP19A1 3365/4885CYP3A4 582/4885CYP1A1 1504/4885 |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | ACACA, FABP4, CUTA | CYP19A1 1948/4885CYP3A4 4033/4885CYP1A1 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.